VitaSmart HOPE System: Bridge to HOPE Registry

Conditions

• End Stage Liver DIsease
• Liver Failure

Eligibility Criteria

Sex

ALL

Age

N/A - N/A

Healthy Volunteers

Not accepted

Interventions

• hypothermic oxygenated perfusion therapy of a donor liver under standard of care conditions — DEVICE
  Observational, real-world use of the VitaSmart HOPE System with a donor liver graft under standard of care conditions.

Study Details

This is a post-market, multicenter, single-arm, observational registry evaluating real-world use of the VitaSmart HOPE System under standard of care conditions. Clinical data from up to 5000 transplant recipients will be included in the registry at up to 20 U.S. transplant centers. This registry will include clinical data collected retrospectively from medical records of recipients already transplanted before the initiation of the registry and any new recipients of livers that meet donor selection criteria. This registry introduces no contact with the transplant recipient and registry participants will follow standard of care. Data will be collected through up to 5 years of standard of care clinical follow-up. This registry represents minimal risk to the transplant recipients being studied. The participants included in this registry will have undergone transplant surgery with a deceased donor liver graft that was perfused using the VitaSmart HOPE System, a medical device that is cleared by the Food and Drug Administration (FDA) for commercial use in the U.S. All perfusions of deceased donor liver grafts will be performed in accordance with standard medical practice. The objectives of this registry is to Evaluate the safety and efficacy of HOPE prior to liver transplantation in real-world clinical settings.

Key Dates

Start date

Sep 30, 2026

Status verified

May 2026

Primary completion

Dec 31, 2028

Completion

Dec 31, 2033

Study Design

Enrollment

5,000 participants (estimated)

Arms

• Arm: Patients undergoing liver transplantation with a donor graft that was perfused using VitaSmart
  Recipients who received a deceased donor liver graft that was perfused using VitaSmart hypothermic oxygenated perfusion therapy.

Primary Outcome Measure

Number of Recipients alive with functioning graft at 1-year post-transplant [ Time Frame: 1-year post-transplant ]

Locations (1)

Find similar trials in Cleveland, OH

Related Studies

• Functional Assessment in Liver Transplantation
  Recruiting · University of California, San Francisco · Little Rock, Arkansas
• Dissemination of the Donor Application: Utilizing Social Media to Identify Potential Live Organ Donors
  Recruiting · Johns Hopkins University · San Diego, California
• Allogenic Hepatocyte Transplantation Into Periduodenal Lymph Nodes
  PHASE2 · Recruiting · LyGenesis, Inc. · Boston, Massachusetts
• Angiotensin 2 for AKI After OLT
  PHASE4 · Enrolling By Invitation · University of California, Los Angeles · Los Angeles, California